Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition
- D. Mager, W. Jusko
- Chemistry, Medicine
- Journal of Pharmacokinetics and Pharmacodynamics
- 1 December 2001
Drugs that bind with high affinity and to a significant extent (relative to dose) to a pharmacologic target such as an enzyme, receptor, or transporter may exhibit nonlinear pharmacokinetic (PK)… Expand
Pharmacokinetics of tacrolimus in liver transplant patients
- W. Jusko, W. Piekoszewski, +6 authors Q. Mekki
- Medicine
- Clinical pharmacology and therapeutics
- 1 March 1995
To characterize the pharmacokinetics of the immunosuppressive agent tacrolimus (FK 506) in liver transplant patients.
Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin After Single and Multiple Doses in Healthy Volunteers
- R. Ramakrishnan, Wing K. Cheung, M. Wacholtz, N. Minton, W. Jusko
- Medicine
- Journal of clinical pharmacology
- 1 September 2004
This study describes a pharmacokinetic (PK) model to account for serum recombinant human erythropoietin (rHuEpo) concentrations in healthy volunteers following intravenous (IV) and subcutaneous (SC)… Expand
Applied pharmacokinetics : principles of therapeutic drug monitoring
- W. E. Evans, Jerome J. Schentag, W. Jusko
- Medicine
- 1986
The Third Edition of Applied Pharmacokinetics remains the gold standard by which all other clinical pharmacokinetics texts are measured. Written by leading pharmacokinetics researchers and… Expand
- 662
- 14
Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis.
- F. D. Boudinot, W. Jusko
- Chemistry, Medicine
- Journal of pharmaceutical sciences
- 1 June 1984
The effects of drug stability, radioactive tracer purity, buffer composition, protein concentration, and fluid shifts on the nonlinear plasma protein binding of prednisolone were examined by… Expand
Diversity of mechanism-based pharmacodynamic models.
- D. Mager, E. Wyska, W. Jusko
- Computer Science, Medicine
- Drug metabolism and disposition: the biological…
- 1 May 2003
TLDR
Physiologically Based Pharmacokinetic Modeling of FTY720 (2-Amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in Rats After Oral and Intravenous Doses
- Guy M L Meno-Tetang, H. Li, +4 authors W. Jusko
- Chemistry, Medicine
- Drug Metabolism and Disposition
- 1 September 2006
FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) is a new sphingosine-1-phosphate receptor agonist being developed for multiple sclerosis and prevention of solid organ… Expand
Modeling of Corticosteroid Pharmacogenomics in Rat Liver Using Gene Microarrays
- Jin Y Jin, R. Almon, D. DuBois, W. Jusko
- Biology, Medicine
- Journal of Pharmacology and Experimental…
- 1 October 2003
Corticosteroid (CS) pharmacogenomics was studied using gene microarrays in rat liver. Methylprednisolone (MPL) was administered intravenously at 50 mg/kg. Rats were sacrificed and liver excised at 17… Expand
Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Interferon-β1a in Monkeys
- D. Mager, B. Neuteboom, C. Efthymiopoulos, A. Munafo, W. Jusko
- Chemistry, Medicine
- Journal of Pharmacology and Experimental…
- 1 July 2003
A pharmacokinetic/pharmacodynamic (PK/PD) model was developed to simultaneously characterize interferon after i.v. and s.c. dosing at various dose levels. A sequential study in monkeys (n = 18) was… Expand
Pharmacodynamic Models for Agents that Alter Production of Natural Cells with Various Distributions of Lifespans
- W. Krzyzanski, S. Woo, W. Jusko
- Biology, Medicine
- Journal of Pharmacokinetics and Pharmacodynamics
- 25 March 2006
Indirect pharmacodynamic response (IDR) models were developed for agents which alter the generation of cell populations with arbitrary lifespan distributions. These models extend lifespan based IDR… Expand